Related Experiment Videos
Amiodarone-an "old" drug with new recommendations
1Pediatric Emergency Medicine, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA. mmckee@cnmc.org
Insights
Amiodarone is an antiarrhythmic drug recommended for pediatric resuscitation. Current pediatric data show limited efficacy, indicating a need for more research before widespread clinical acceptance.
Area of Science:
- Cardiology
- Pediatric Emergency Medicine
- Pharmacology
Background:
- Amiodarone is an antiarrhythmic medication gaining attention following revised pediatric resuscitation guidelines.
- While adult use is well-supported, pediatric data on amiodarone efficacy is limited.
- There is a critical need for more research on amiodarone in pediatric acute resuscitation.
Purpose of the Study:
- To review amiodarone properties relevant to pediatric resuscitation.
- To analyze existing pediatric studies on amiodarone's efficacy and safety.
- To provide healthcare providers with information for informed antiarrhythmic choices in pediatric emergencies.
Main Methods:
- Literature review of amiodarone properties.
- Analysis of published pediatric studies concerning amiodarone use in resuscitation.
- Discussion of the challenges in conducting prospective pediatric trials.
Main Results:
- Limited pediatric studies indicate restricted efficacy of amiodarone.
- Existing research highlights a significant need for further pediatric data.
- Controlled prospective studies in pediatric resuscitation are ethically challenging.
Conclusions:
- Healthcare providers must carefully evaluate the available pediatric evidence for amiodarone.
- The current pediatric data may not support the widespread adoption of amiodarone in treatment regimens.
- Further investigation is crucial to determine amiodarone's role in pediatric acute resuscitation.
Abstract:
Amiodarone has gained recognition as an antiarrhythmic medication after recent publication of the newly revised American Heart Association guidelines for pediatric resuscitation. Although support for the widespread use of amiodarone in adults has been supported by research, the few pediatric studies demonstrate limited efficacy and highlight the need for additional data. Because of the nature of the need for this type of resuscitation medication, controlled prospective studies will be difficult to obtain if not morally contraindicated. This article reviews the properties of amiodarone and the pertinent pediatric studies to provide healthcare providers supplemental information regarding amiodarone when choosing antiarrhythmics for acute resuscitation. Individual providers need to discern whether the pediatric data available supports widespread acceptance into current treatment regimens.